Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study

5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD). To study the growth pattern in Chinese pediatric patients with 5αRD. Data were obtained from 141 patients with 5αRD (age: 0-16 years old) who visited eight pe...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 10; p. 173
Main Authors Zhao, Xiu, Song, Yanning, Chen, Shaoke, Wang, Xiumin, Luo, Feihong, Yang, Yu, Chen, Linqi, Chen, Ruimin, Chen, Hui, Su, Zhe, Wu, Di, Gong, Chunxiu
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 15.03.2019
Subjects
Online AccessGet full text
ISSN1663-9812
1663-9812
DOI10.3389/fphar.2019.00173

Cover

Abstract 5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD). To study the growth pattern in Chinese pediatric patients with 5αRD. Data were obtained from 141 patients with 5αRD (age: 0-16 years old) who visited eight pediatric endocrine centers from January 2010 to December 2017. In this retrospective cohort study, height, weight, and other relevant data were collected from the multicenter hospital registration database. Baseline luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), and dihydrotestosterone (DHT) after human chorionic gonadotropin (HCG) stimulation test were measured by enzyme enhanced chemiluminescence assay. Bone age (BA) was assessed using the Greulich-Pyle (G-P) atlas. Growth curve was constructed based on λ-median-coefficient of variation method (LMS). The height standard deviation scores (HtSDS) and weight standard deviation scores (WtSDS) in 5αRD children were in the normal range as compared to normal boys. Significantly higher HtSDS was observed in patients with 5αRD who were <1 year old ( = 3.658, 2.103, = 0.002, 0.048, respectively), and higher WtSDS in those <6 months old ( = 2.756, = 0.012). Then HtSDS and WtSDS decreased gradually and fluctuated near the median of the same age until 13 years. WtSDS in 5αRD children from northern China were significantly higher than those from the south ( = -2.670, = 0.008). The variation tendency of HtSDS in Chinese 5αRDs was consistent with the trend of stimulating T. HtSDS and stimulating T in the external masculinization score (EMS) <7 group were slightly higher than those in EMS ≥ 7 group without significant difference. Additionally, the ratio of BA over chronological age (BA/CA) was significantly <1 in children with 5αRD. Children with 5αRD had a special growth pattern that was affected by high levels of T, while DHT played a very small role in it. Their growth accelerated at age <1 year, followed by slowing growth and fluctuating height near normal median boys' height. The BA was delayed in 5αRD children. Androgen treatment, which may be considered anyway for male 5αRD patients with a micropenis, may also be beneficial for growth.
AbstractList 5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD).BACKGROUND5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD).To study the growth pattern in Chinese pediatric patients with 5αRD.OBJECTIVETo study the growth pattern in Chinese pediatric patients with 5αRD.Data were obtained from 141 patients with 5αRD (age: 0-16 years old) who visited eight pediatric endocrine centers from January 2010 to December 2017.SUBJECTSData were obtained from 141 patients with 5αRD (age: 0-16 years old) who visited eight pediatric endocrine centers from January 2010 to December 2017.In this retrospective cohort study, height, weight, and other relevant data were collected from the multicenter hospital registration database. Baseline luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), and dihydrotestosterone (DHT) after human chorionic gonadotropin (HCG) stimulation test were measured by enzyme enhanced chemiluminescence assay. Bone age (BA) was assessed using the Greulich-Pyle (G-P) atlas. Growth curve was constructed based on λ-median-coefficient of variation method (LMS).METHODSIn this retrospective cohort study, height, weight, and other relevant data were collected from the multicenter hospital registration database. Baseline luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), and dihydrotestosterone (DHT) after human chorionic gonadotropin (HCG) stimulation test were measured by enzyme enhanced chemiluminescence assay. Bone age (BA) was assessed using the Greulich-Pyle (G-P) atlas. Growth curve was constructed based on λ-median-coefficient of variation method (LMS).The height standard deviation scores (HtSDS) and weight standard deviation scores (WtSDS) in 5αRD children were in the normal range as compared to normal boys. Significantly higher HtSDS was observed in patients with 5αRD who were <1 year old (t = 3.658, 2.103, P = 0.002, 0.048, respectively), and higher WtSDS in those <6 months old (t = 2.756, P = 0.012). Then HtSDS and WtSDS decreased gradually and fluctuated near the median of the same age until 13 years. WtSDS in 5αRD children from northern China were significantly higher than those from the south (Z = -2.670, P = 0.008). The variation tendency of HtSDS in Chinese 5αRDs was consistent with the trend of stimulating T. HtSDS and stimulating T in the external masculinization score (EMS) <7 group were slightly higher than those in EMS ≥ 7 group without significant difference. Additionally, the ratio of BA over chronological age (BA/CA) was significantly <1 in children with 5αRD.RESULTSThe height standard deviation scores (HtSDS) and weight standard deviation scores (WtSDS) in 5αRD children were in the normal range as compared to normal boys. Significantly higher HtSDS was observed in patients with 5αRD who were <1 year old (t = 3.658, 2.103, P = 0.002, 0.048, respectively), and higher WtSDS in those <6 months old (t = 2.756, P = 0.012). Then HtSDS and WtSDS decreased gradually and fluctuated near the median of the same age until 13 years. WtSDS in 5αRD children from northern China were significantly higher than those from the south (Z = -2.670, P = 0.008). The variation tendency of HtSDS in Chinese 5αRDs was consistent with the trend of stimulating T. HtSDS and stimulating T in the external masculinization score (EMS) <7 group were slightly higher than those in EMS ≥ 7 group without significant difference. Additionally, the ratio of BA over chronological age (BA/CA) was significantly <1 in children with 5αRD.Children with 5αRD had a special growth pattern that was affected by high levels of T, while DHT played a very small role in it. Their growth accelerated at age <1 year, followed by slowing growth and fluctuating height near normal median boys' height. The BA was delayed in 5αRD children. Androgen treatment, which may be considered anyway for male 5αRD patients with a micropenis, may also be beneficial for growth.CONCLUSIONChildren with 5αRD had a special growth pattern that was affected by high levels of T, while DHT played a very small role in it. Their growth accelerated at age <1 year, followed by slowing growth and fluctuating height near normal median boys' height. The BA was delayed in 5αRD children. Androgen treatment, which may be considered anyway for male 5αRD patients with a micropenis, may also be beneficial for growth.
Background5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD).ObjectiveTo study the growth pattern in Chinese pediatric patients with 5αRD.SubjectsData were obtained from 141 patients with 5αRD (age: 0–16 years old) who visited eight pediatric endocrine centers from January 2010 to December 2017.MethodsIn this retrospective cohort study, height, weight, and other relevant data were collected from the multicenter hospital registration database. Baseline luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), and dihydrotestosterone (DHT) after human chorionic gonadotropin (HCG) stimulation test were measured by enzyme enhanced chemiluminescence assay. Bone age (BA) was assessed using the Greulich-Pyle (G-P) atlas. Growth curve was constructed based on λ-median-coefficient of variation method (LMS).ResultsThe height standard deviation scores (HtSDS) and weight standard deviation scores (WtSDS) in 5αRD children were in the normal range as compared to normal boys. Significantly higher HtSDS was observed in patients with 5αRD who were <1 year old (t = 3.658, 2.103, P = 0.002, 0.048, respectively), and higher WtSDS in those <6 months old (t = 2.756, P = 0.012). Then HtSDS and WtSDS decreased gradually and fluctuated near the median of the same age until 13 years. WtSDS in 5αRD children from northern China were significantly higher than those from the south (Z = -2.670, P = 0.008). The variation tendency of HtSDS in Chinese 5αRDs was consistent with the trend of stimulating T. HtSDS and stimulating T in the external masculinization score (EMS) <7 group were slightly higher than those in EMS ≥ 7 group without significant difference. Additionally, the ratio of BA over chronological age (BA/CA) was significantly <1 in children with 5αRD.ConclusionChildren with 5αRD had a special growth pattern that was affected by high levels of T, while DHT played a very small role in it. Their growth accelerated at age <1 year, followed by slowing growth and fluctuating height near normal median boys’ height. The BA was delayed in 5αRD children. Androgen treatment, which may be considered anyway for male 5αRD patients with a micropenis, may also be beneficial for growth.
5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD). To study the growth pattern in Chinese pediatric patients with 5αRD. Data were obtained from 141 patients with 5αRD (age: 0-16 years old) who visited eight pediatric endocrine centers from January 2010 to December 2017. In this retrospective cohort study, height, weight, and other relevant data were collected from the multicenter hospital registration database. Baseline luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), and dihydrotestosterone (DHT) after human chorionic gonadotropin (HCG) stimulation test were measured by enzyme enhanced chemiluminescence assay. Bone age (BA) was assessed using the Greulich-Pyle (G-P) atlas. Growth curve was constructed based on λ-median-coefficient of variation method (LMS). The height standard deviation scores (HtSDS) and weight standard deviation scores (WtSDS) in 5αRD children were in the normal range as compared to normal boys. Significantly higher HtSDS was observed in patients with 5αRD who were <1 year old ( = 3.658, 2.103, = 0.002, 0.048, respectively), and higher WtSDS in those <6 months old ( = 2.756, = 0.012). Then HtSDS and WtSDS decreased gradually and fluctuated near the median of the same age until 13 years. WtSDS in 5αRD children from northern China were significantly higher than those from the south ( = -2.670, = 0.008). The variation tendency of HtSDS in Chinese 5αRDs was consistent with the trend of stimulating T. HtSDS and stimulating T in the external masculinization score (EMS) <7 group were slightly higher than those in EMS ≥ 7 group without significant difference. Additionally, the ratio of BA over chronological age (BA/CA) was significantly <1 in children with 5αRD. Children with 5αRD had a special growth pattern that was affected by high levels of T, while DHT played a very small role in it. Their growth accelerated at age <1 year, followed by slowing growth and fluctuating height near normal median boys' height. The BA was delayed in 5αRD children. Androgen treatment, which may be considered anyway for male 5αRD patients with a micropenis, may also be beneficial for growth.
Author Chen, Shaoke
Chen, Hui
Gong, Chunxiu
Wang, Xiumin
Chen, Linqi
Luo, Feihong
Su, Zhe
Yang, Yu
Chen, Ruimin
Wu, Di
Zhao, Xiu
Song, Yanning
AuthorAffiliation 1 Center of Endocrinology, Genetics and Metabolism, National Center for Children’s Health, Beijing Children’s Hospital, Capital Medical University , Beijing , China
3 Genetic and Metabolic Central Laboratory, Maternal and Children Health Hospital of Guangxi Zhuang Autonomous Region , Nanning , China
6 Department of Endocrinology, Jiangxi Provincial Children’s Hospital , Nanchang , China
4 Department of Endocrinology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University , Shanghai , China
5 Department of Endocrinology, Children’s Hospital of Fudan University, Fudan University , Shanghai , China
7 Department of Endocrinology, Children’s Hospital of Soochow University , Suzhou , China
2 Department of Endocrinology, Shenzhen Children’s Hospital , Shenzhen , China
8 Department of Endocrinology, Fuzhou Children’s Hospital , Fuzhou , China
9 Department of BME, Capital Medical University , Beijing , China
AuthorAffiliation_xml – name: 3 Genetic and Metabolic Central Laboratory, Maternal and Children Health Hospital of Guangxi Zhuang Autonomous Region , Nanning , China
– name: 5 Department of Endocrinology, Children’s Hospital of Fudan University, Fudan University , Shanghai , China
– name: 7 Department of Endocrinology, Children’s Hospital of Soochow University , Suzhou , China
– name: 9 Department of BME, Capital Medical University , Beijing , China
– name: 6 Department of Endocrinology, Jiangxi Provincial Children’s Hospital , Nanchang , China
– name: 2 Department of Endocrinology, Shenzhen Children’s Hospital , Shenzhen , China
– name: 1 Center of Endocrinology, Genetics and Metabolism, National Center for Children’s Health, Beijing Children’s Hospital, Capital Medical University , Beijing , China
– name: 4 Department of Endocrinology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University , Shanghai , China
– name: 8 Department of Endocrinology, Fuzhou Children’s Hospital , Fuzhou , China
Author_xml – sequence: 1
  givenname: Xiu
  surname: Zhao
  fullname: Zhao, Xiu
– sequence: 2
  givenname: Yanning
  surname: Song
  fullname: Song, Yanning
– sequence: 3
  givenname: Shaoke
  surname: Chen
  fullname: Chen, Shaoke
– sequence: 4
  givenname: Xiumin
  surname: Wang
  fullname: Wang, Xiumin
– sequence: 5
  givenname: Feihong
  surname: Luo
  fullname: Luo, Feihong
– sequence: 6
  givenname: Yu
  surname: Yang
  fullname: Yang, Yu
– sequence: 7
  givenname: Linqi
  surname: Chen
  fullname: Chen, Linqi
– sequence: 8
  givenname: Ruimin
  surname: Chen
  fullname: Chen, Ruimin
– sequence: 9
  givenname: Hui
  surname: Chen
  fullname: Chen, Hui
– sequence: 10
  givenname: Zhe
  surname: Su
  fullname: Su, Zhe
– sequence: 11
  givenname: Di
  surname: Wu
  fullname: Wu, Di
– sequence: 12
  givenname: Chunxiu
  surname: Gong
  fullname: Gong, Chunxiu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30930770$$D View this record in MEDLINE/PubMed
BookMark eNp1ks9u1DAQxi1URNuld07IRy5Z_G9jmwNStUCpVAQqRRwtx550vcomqeMU7WP1RXgmnN0WtUj4MpZn5vfZnu8YHbRdCwi9omTOudJv635l45wRqueEUMmfoSNalrzQirKDR_tDdDIMa5IX15qX4gU65ERzIiU5Quuz2P1KK_zNpgSxxaHFy1VoYYApNj5Ci3-GXLD4fVdcgh9dsjl3te0BM_wB6uACtG77Dp_iS0ixG3pwKdwC_jI2KThoMxZ_T6PfvkTPa9sMcHIfZ-jHp49Xy8_Fxdez8-XpReFEyVIhiAYuuKWMOyugLqmuvFasVsp6SqvSSk8EJ15wocBrryQAc7UgdGGtZHyGzvdc39m16WPY2Lg1nQ1md9DFa2NjvloDRjImSV1TC6QSFSi9kKKUlHIoa1BZYYbe71n9WG3AT8-JtnkCfZppw8pcd7emFExrpTLgzT0gdjcjDMlswuCgaWwL3TgYlucn8_DEpPX6sdZfkYdh5YJyX-DyNw8RauNCsil0k3RoDCVmMobZGcNMxjA7Y-RG8k_jA_u_LX8AQDa9Fw
CitedBy_id crossref_primary_10_1002_ped4_12302
crossref_primary_10_3390_jpm12050771
crossref_primary_10_1155_2022_6025916
Cites_doi 10.1249/JES.0000000000000056
10.1007/s42000-018-0013-9
10.4274/jcrpe.2782
10.1007/s12098-017-2412-3
10.3969/j.issn.1673-5501.2012.03.002
10.1152/physrev.00033.2015
10.1016/j.jsbmb.2016.05.020
10.1007/s11427-017-9100-1
10.1172/JCI116665
10.1007/s11427-017-9084-9
10.1101/gr.107524.110
10.1002/0471250953.bi1110s43
10.1210/jc.2004-1303
10.1056/NEJM197212212872508
10.1210/jc.2008-2108
10.1023/A:1005326027087
10.1038/ng.806
10.1007/s00431-004-1406-0
10.1542/peds.2006-0738
10.1159/000076279
10.1515/jpem-2008-210609
10.1046/j.1464-410x.2000.00354.x
10.1210/jc.2004-1314
10.1159/000439234
10.1002/(SICI)1096-8628(19960503)63:1<223::AID-AJMG39>3.0.CO;2-O
10.1136/adc.65.10.1166
10.1038/sj.ejhg.5201232
10.1515/jpem-2016-0048
10.1111/j.1365-2265.2007.02960.x
10.1002/ajmg.c.31560
10.1210/jc.2001-011902
10.1210/edrv-14-5-577
10.1002/sim.4780111005
10.1155/2012/964876
10.1542/peds.2014-1088
10.1002/jbmr.552
10.4274/jcrpe.2495
10.1159/000271915
10.3760/cma.j.issn.0578-1310.2010.06.005
10.1002/ped4.12010
10.1210/er.2014-1024
10.1360/N972015-01212
10.1038/gim.2015.30
10.1210/jc.2011-0298
10.1111/j.1365-2265.2005.02348.x
10.1159/000315961
10.1093/humupd/7.3.314
10.1159/000445090
10.1136/fn.87.2.F150
10.1007/s11427-017-9099-3
10.1152/ajpendo.00311.2005
10.1093/molehr/gaq072
10.1530/EJE-08-0166
ContentType Journal Article
Copyright Copyright © 2019 Zhao, Song, Chen, Wang, Luo, Yang, Chen, Chen, Chen, Su, Wu and Gong. 2019 Zhao, Song, Chen, Wang, Luo, Yang, Chen, Chen, Chen, Su, Wu and Gong
Copyright_xml – notice: Copyright © 2019 Zhao, Song, Chen, Wang, Luo, Yang, Chen, Chen, Chen, Su, Wu and Gong. 2019 Zhao, Song, Chen, Wang, Luo, Yang, Chen, Chen, Chen, Su, Wu and Gong
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fphar.2019.00173
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals (WRLC)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1663-9812
ExternalDocumentID oai_doaj_org_article_72270ff1ae0b4be8957467113e6fe8d4
PMC6429988
30930770
10_3389_fphar_2019_00173
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
RNS
RPM
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c462t-409e343a123ca4ef619bd982f88ad11b6a7d0430d4348ed9d87ee2cf4015aa723
IEDL.DBID M48
ISSN 1663-9812
IngestDate Wed Aug 27 01:26:56 EDT 2025
Thu Aug 21 18:32:50 EDT 2025
Fri Sep 05 05:43:26 EDT 2025
Thu Jan 02 22:54:18 EST 2025
Thu Apr 24 22:58:39 EDT 2025
Tue Jul 01 03:27:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords 46
5α-reductase type 2 deficiency
testosterone
children
XY DSD
dihydrotestosterone
height
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-409e343a123ca4ef619bd982f88ad11b6a7d0430d4348ed9d87ee2cf4015aa723
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Tieliu Shi, East China Normal University, China
These authors have contributed equally to this work
This article was submitted to Translational Pharmacology, a section of the journal Frontiers in Pharmacology
Reviewed by: Michaël R. Laurent, University Hospitals Leuven, Belgium; Chao Xu, Shandong Qianfoshan Hospital, China; Michel Polak, Necker-Enfants Malades Hospital, France
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2019.00173
PMID 30930770
PQID 2201717344
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_72270ff1ae0b4be8957467113e6fe8d4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6429988
proquest_miscellaneous_2201717344
pubmed_primary_30930770
crossref_citationtrail_10_3389_fphar_2019_00173
crossref_primary_10_3389_fphar_2019_00173
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-03-15
PublicationDateYYYYMMDD 2019-03-15
PublicationDate_xml – month: 03
  year: 2019
  text: 2019-03-15
  day: 15
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in pharmacology
PublicationTitleAlternate Front Pharmacol
PublicationYear 2019
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Shen (B37) 2016; 61
Di (B12) 2013; 8
Richter-Unruh (B36) 2004; 163
Lee (B23) 2006; 118
Ishii (B17) 2015; 84
Raveenthiran (B34) 2017; 84
Ittiwut (B19) 2017; 30
Ni (B28) 2017; 60
Yarrow (B57) 2015; 43
Kolesinska (B22) 2014; 134
Veiga-Junior (B46) 2012; 2012
Ko (B21) 2010; 73
Van der Auwera (B44) 2013; 43
Mendonca (B26) 2016; 163
Bertelloni (B4) 2016; 10
Chen (B7) 2012; 7
Perry (B32) 2008; 68
Wang (B52) 2017; 60
Wilson (B55) 1993; 14
Wang (B53) 2004; 12
Ahmed (B1) 2000; 85
Ng (B27) 1990; 65
Issa (B18) 2002; 87
Nicoletti (B29) 2005; 63
Tria (B43) 2004; 61
Choi (B8) 2008; 21
Sultan (B41) 2001; 7
Veldhuis (B48); 90
Deeb (B10) 2016; 8
Sims (B39) 2006; 290
(B33) 2010; 48
Sinnecker (B40) 1996; 63
Wu (B56) 2017; 1
Li (B24) 2009; 47
Bertelloni (B5) 2010; 4
Eren (B13) 2016; 8
McKenna (B25) 2010; 20
Silver (B38) 1999
Vanderschueren (B45) 2014; 35
Hughes (B16) 2002; 87
Jia (B20) 2017; 60
Byers (B6) 2017; 175
Almeida (B2) 2017; 97
Thigpen (B42) 1993; 92
Wilson (B54) 1972; 287
Veldhuis (B49) 2011; 96
Veldhuis (B51) 2009; 94
Avendano (B3) 2018; 17
DePristo (B11) 2011; 43
Gad (B14) 1997; 20
Han (B15) 2008; 159
Nie (B30) 2011; 17
Nishiyama (B31) 2012; 27
Veldhuis (B47); 90
Veldhuis (B50) 1997; 82
Cole (B9) 1992; 11
Richards (B35) 2015; 17
References_xml – volume: 43
  start-page: 222
  year: 2015
  ident: B57
  article-title: Testosterone and adult male bone: actions independent of 5alpha-reductase and aromatase.
  publication-title: Exerc. Sport Sci. Rev.
  doi: 10.1249/JES.0000000000000056
– volume: 17
  start-page: 197
  year: 2018
  ident: B3
  article-title: 5-alpha-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review.
  publication-title: Hormones
  doi: 10.1007/s42000-018-0013-9
– volume: 8
  start-page: 236
  year: 2016
  ident: B10
  article-title: Phenotype, sex of rearing, gender re-assignment, and response to medical treatment in extended family members with a novel mutation in the SRD5A2 gene.
  publication-title: J. Clin. Res. Pediatr. Endocrinol.
  doi: 10.4274/jcrpe.2782
– volume: 84
  start-page: 700
  year: 2017
  ident: B34
  article-title: Controversies of sex re-assignment in genetic males with congenital inadequacy of the penis.
  publication-title: Indian Pediatr. J.
  doi: 10.1007/s12098-017-2412-3
– volume: 7
  start-page: 167
  year: 2012
  ident: B7
  article-title: Clinical observation of short-term oral testosterone undecanoate treatment for 46, XY DSD Chinese boys with small penis: a self-comparison study.
  publication-title: Clin. J. Evid. Based Pediatr.
  doi: 10.3969/j.issn.1673-5501.2012.03.002
– volume: 97
  start-page: 135
  year: 2017
  ident: B2
  article-title: Estrogens and androgens in skeletal physiology and pathophysiology.
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00033.2015
– volume: 163
  start-page: 206
  year: 2016
  ident: B26
  article-title: Steroid 5alpha-reductase 2 deficiency.
  publication-title: J. Steroid Biochem. Mol. Biol.
  doi: 10.1016/j.jsbmb.2016.05.020
– volume: 60
  start-page: 681
  year: 2017
  ident: B28
  article-title: The challenge and promise of rare disease diagnosis in China.
  publication-title: Sci. China Life Sci.
  doi: 10.1007/s11427-017-9100-1
– volume: 92
  start-page: 903
  year: 1993
  ident: B42
  article-title: Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.
  publication-title: Clin. J. Invest.
  doi: 10.1172/JCI116665
– volume: 60
  start-page: 700
  year: 2017
  ident: B52
  article-title: AR mutations in 28 patients with androgen insensitivity syndrome (Prader grade 0-3).
  publication-title: Sci. China Life Sci.
  doi: 10.1007/s11427-017-9084-9
– volume: 20
  start-page: 1297
  year: 2010
  ident: B25
  article-title: The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
  publication-title: Genome Res.
  doi: 10.1101/gr.107524.110
– volume: 43
  start-page: 1
  year: 2013
  ident: B44
  article-title: From FastQ data to high confidence variant calls: the genome analysis toolkit best practices pipeline.
  publication-title: Curr. Protoc. Bioinformatics
  doi: 10.1002/0471250953.bi1110s43
– volume: 90
  start-page: 1613
  ident: B47
  article-title: Testosterone blunts feedback inhibition of growth hormone secretion by experimentally elevated insulin-like growth factor-I concentrations.
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2004-1303
– volume: 287
  start-page: 1284
  year: 1972
  ident: B54
  article-title: Recent studies on the mechanism of action of testosterone.
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM197212212872508
– volume: 94
  start-page: 973
  year: 2009
  ident: B51
  article-title: Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men.
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2008-2108
– volume: 20
  start-page: 95
  year: 1997
  ident: B14
  article-title: 5 alpha-reductase deficiency in patients with micropenis.
  publication-title: Inherit. J. Metab. Dis.
  doi: 10.1023/A:1005326027087
– volume: 47
  start-page: 487
  year: 2009
  ident: B24
  article-title: [Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years].
  publication-title: Zhonghua Er Ke Za Zhi
– volume: 43
  start-page: 491
  year: 2011
  ident: B11
  article-title: A framework for variation discovery and genotyping using next-generation DNA sequencing data.
  publication-title: Nat. Genet.
  doi: 10.1038/ng.806
– volume: 163
  start-page: 251
  year: 2004
  ident: B36
  article-title: Short stature in children with an apparently normal male phenotype can be caused by 45,X/46,XY mosaicism and is susceptible to growth hormone treatment.
  publication-title: Eur. Pediatr. J.
  doi: 10.1007/s00431-004-1406-0
– volume: 118
  start-page: e488
  year: 2006
  ident: B23
  article-title: Consensus statement on management of intersex disorders. International consensus conference on intersex.
  publication-title: Pediatrics
  doi: 10.1542/peds.2006-0738
– volume: 61
  start-page: 180
  year: 2004
  ident: B43
  article-title: Steroid 5alpha-reductase 1 polymorphisms and testosterone/dihydrotestosterone ratio in male patients with hypospadias.
  publication-title: Horm. Res.
  doi: 10.1159/000076279
– volume: 21
  start-page: 545
  year: 2008
  ident: B8
  article-title: Molecular analysis of the AR and SRD5A2 genes in patients with 46,XY disorders of sex development.
  publication-title: J. Pediatr. Endocrinol. Metab.
  doi: 10.1515/jpem-2008-210609
– volume: 85
  start-page: 120
  year: 2000
  ident: B1
  article-title: The role of a clinical score in the assessment of ambiguous genitalia.
  publication-title: BJU Int.
  doi: 10.1046/j.1464-410x.2000.00354.x
– volume: 90
  start-page: 2941
  ident: B48
  article-title: Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrations.
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2004-1314
– volume: 84
  start-page: 305
  year: 2015
  ident: B17
  article-title: Human chorionic gonadotropin stimulation test in prepubertal children with micropenis can accurately predict leydig cell function in pubertal or postpubertal adolescents.
  publication-title: Horm. Res. Paediatr.
  doi: 10.1159/000439234
– volume: 63
  start-page: 223
  year: 1996
  ident: B40
  article-title: Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency.
  publication-title: Am. J. Med. Genet.
  doi: 10.1002/(SICI)1096-8628(19960503)63:1<223::AID-AJMG39>3.0.CO;2-O
– volume: 65
  start-page: 1166
  year: 1990
  ident: B27
  article-title: 5 alpha-reductase deficiency without hypospadias.
  publication-title: Arch. Dis. Child.
  doi: 10.1136/adc.65.10.1166
– volume: 12
  start-page: 706
  year: 2004
  ident: B53
  article-title: Mutation analysis of five candidate genes in Chinese patients with hypospadias.
  publication-title: Eur. Hum, J. Genet.
  doi: 10.1038/sj.ejhg.5201232
– start-page: 1142
  year: 1999
  ident: B38
  article-title: 5alpha-reductase type 2 mutations are present in some boys with isolated hypospadias.
  publication-title: J. Urol.
– volume: 30
  start-page: 19
  year: 2017
  ident: B19
  article-title: Novel mutations of the SRD5A2 and AR genes in Thai patients with 46, XY disorders of sex development.
  publication-title: J. Pediatr. Endocrinol. Metab.
  doi: 10.1515/jpem-2016-0048
– volume: 68
  start-page: 4
  year: 2008
  ident: B32
  article-title: The role of sex steroids in controlling pubertal growth.
  publication-title: Clin. Endocrinol.
  doi: 10.1111/j.1365-2265.2007.02960.x
– volume: 175
  start-page: 260
  year: 2017
  ident: B6
  article-title: Unexpected ethical dilemmas in sex assignment in 46,XY DSD due to 5-alpha reductase type 2 deficiency.
  publication-title: Am. J. Med. Genet. C Semin. Med. Genet.
  doi: 10.1002/ajmg.c.31560
– volume: 87
  start-page: 5401
  year: 2002
  ident: B18
  article-title: Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2001-011902
– volume: 14
  start-page: 577
  year: 1993
  ident: B55
  article-title: Steroid 5 alpha-reductase 2 deficiency.
  publication-title: Endocr. Rev.
  doi: 10.1210/edrv-14-5-577
– volume: 11
  start-page: 1305
  year: 1992
  ident: B9
  article-title: Smoothing reference centile curves: the LMS method and penalized likelihood.
  publication-title: Stat. Med.
  doi: 10.1002/sim.4780111005
– volume: 2012
  year: 2012
  ident: B46
  article-title: Clinical and laboratorial features that may differentiate 46,XY DSD due to partial androgen insensitivity and 5alpha-reductase type 2 deficiency.
  publication-title: Int. Endocrinol. J.
  doi: 10.1155/2012/964876
– volume: 82
  start-page: 3414
  year: 1997
  ident: B50
  article-title: Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement∗.
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 134
  start-page: e710
  year: 2014
  ident: B22
  article-title: Changes over time in sex assignment for disorders of sex development.
  publication-title: Pediatrics
  doi: 10.1542/peds.2014-1088
– volume: 27
  start-page: 273
  year: 2012
  ident: B31
  article-title: Cortical porosity is higher in boys compared with girls at the distal radius and distal tibia during pubertal growth: an HR-pQCT study.
  publication-title: Bone J. Miner. Res.
  doi: 10.1002/jbmr.552
– volume: 8
  start-page: 218
  year: 2016
  ident: B13
  article-title: Homozygous Ala65Pro mutation with V89L polymorphism in SRD5A2 deficiency.
  publication-title: J. Clin. Res. Pediatr. Endocrinol.
  doi: 10.4274/jcrpe.2495
– volume: 73
  start-page: 41
  year: 2010
  ident: B21
  article-title: Clinical characterization and analysis of the SRD5A2 gene in six Korean patients with 5alpha-reductase type 2 deficiency.
  publication-title: Horm. Res. Paediatr.
  doi: 10.1159/000271915
– volume: 48
  start-page: 418
  year: 2010
  ident: B33
  article-title: Testis volume.pubic hair development and spernmrcheal age in urban Chinese boys.
  publication-title: Chinese J. Pediatr.
  doi: 10.3760/cma.j.issn.0578-1310.2010.06.005
– volume: 1
  start-page: 16
  year: 2017
  ident: B56
  article-title: Physical assessment and reference growth curves for children with 46,XY disorders of sex development.
  publication-title: Pediatr. Invest.
  doi: 10.1002/ped4.12010
– volume: 35
  start-page: 906
  year: 2014
  ident: B45
  article-title: Sex steroid actions in male bone.
  publication-title: Endocr. Rev.
  doi: 10.1210/er.2014-1024
– volume: 61
  start-page: 1733
  year: 2016
  ident: B37
  article-title: What are the biological roots of sexual orientation?
  publication-title: Chin. Sci. Bull.
  doi: 10.1360/N972015-01212
– volume: 17
  start-page: 405
  year: 2015
  ident: B35
  article-title: Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology.
  publication-title: Genet. Med.
  doi: 10.1038/gim.2015.30
– volume: 96
  start-page: 2540
  year: 2011
  ident: B49
  article-title: Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men.
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2011-0298
– volume: 63
  start-page: 375
  year: 2005
  ident: B29
  article-title: SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects.
  publication-title: Clin. Endocrinol.
  doi: 10.1111/j.1365-2265.2005.02348.x
– volume: 4
  start-page: 270
  year: 2010
  ident: B5
  article-title: Bone health in disorders of sex differentiation.
  publication-title: Sex. Dev.
  doi: 10.1159/000315961
– volume: 7
  start-page: 314
  year: 2001
  ident: B41
  article-title: Disorders linked to insufficient androgen action in male children.
  publication-title: Hum. Reprod. Update
  doi: 10.1093/humupd/7.3.314
– volume: 10
  start-page: 28
  year: 2016
  ident: B4
  article-title: 5alpha-reductase-2 deficiency: clinical findings, endocrine pitfalls, and genetic features in a large italian cohort.
  publication-title: Sex. Dev.
  doi: 10.1159/000445090
– volume: 87
  start-page: F150
  year: 2002
  ident: B16
  article-title: Reduced birth weight in boys with hypospadias: an index of androgen dysfunction?
  publication-title: Arch. Dis. Child Fetal Neonatal Ed.
  doi: 10.1136/fn.87.2.F150
– volume: 60
  start-page: 686
  year: 2017
  ident: B20
  article-title: Towards efficiency in rare disease research: what is distinctive and important?
  publication-title: Sci. China Life Sci.
  doi: 10.1007/s11427-017-9099-3
– volume: 290
  start-page: E456
  year: 2006
  ident: B39
  article-title: Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling.
  publication-title: Am. J. Physiol. Endocrinol. Metab.
  doi: 10.1152/ajpendo.00311.2005
– volume: 8
  start-page: 46
  year: 2013
  ident: B12
  article-title: Analysis of the clinical characteristics and body height in 153 disorders of sex development children without known cause.
  publication-title: Chin. J. Evid. Based Pediatr.
– volume: 17
  start-page: 57
  year: 2011
  ident: B30
  article-title: Five novel mutations of SRD5A2 found in eight Chinese patients with 46,XY disorders of sex development.
  publication-title: Mol. Hum. Reprod.
  doi: 10.1093/molehr/gaq072
– volume: 159
  start-page: 179
  year: 2008
  ident: B15
  article-title: Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis.
  publication-title: Eur. Endocrinol, J.
  doi: 10.1530/EJE-08-0166
SSID ssj0000399364
Score 2.2282948
Snippet 5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD). To study the...
5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development...
Background5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 173
SubjectTerms 5α-reductase type 2 deficiency
dihydrotestosterone
height
Pharmacology
testosterone
XY DSD
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ3NatwwEIBFyamXkv6k2bYpKpRAIWZt_Vhyb2naJARalpDQ3IRsj9gtxRt2ncM-Vl8kz9QZ2bvZLSG59GrL9qAZe2YszTeMfUxDCJn1IalsrRNVpirxRueJDXkopEenGOh_x_cf-emlOrvSV2utvmhPWIcH7iZuaIQweMPMQ1qqEmyhqUFGlknIA9g6kkDTIl1LpuI3mPxurrp1SczCimG4Hnvif2aRT2nkhh-KuP77Ysx_t0qu-Z7jbfasDxr5YSfsc_YEmhdsf9RRpxcH_OKuiGp-wPf56I5HvXjJfp1gqt2O-SiiNBs-aTh1zYY58KO-lJv_nOAAffsnOSeUa4uujVOGygX_CsSYoALNz_yQn0M7my6rM3ms3iWZYcZpQ-LiFbs8_nZxdJr0LRaSSuWixeyxAKmkR_9VeQUB06myLqwI1vo6y8rcm5qoYLWSykJd1NYAiCpgVqa9N0LusK1m2sAu41ZbifoB61FRMvU-FMKj4krtFVHxBmy4nHBX9fxxaoPx22EeQipyUUWOVOSiigbs0-qK64698cDYL6TD1TiiZscDaEuutyX3mC0N2IelBTh8y2jpxDcwvZk7IYgrZKTCMa87i1g9itaSU2PSATMbtrIhy-aZZjKOJO-cogFr3_wP4d-ypzQdtD8u0-_YVju7gT0MmNryfXw3_gIsKhZE
  priority: 102
  providerName: Directory of Open Access Journals
Title Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study
URI https://www.ncbi.nlm.nih.gov/pubmed/30930770
https://www.proquest.com/docview/2201717344
https://pubmed.ncbi.nlm.nih.gov/PMC6429988
https://doaj.org/article/72270ff1ae0b4be8957467113e6fe8d4
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fa9RAEF-0vvgi_ve0lhWkIDQ22exmN4JIrdYiKEfpYd-WTTLbOym5NpeC97H8In4mZza5O08On3xNdsmwM5OZ2Zn5DWMvY-99YpyPSlOpSBaxjJxWWWR85vPUoVH0dN_x5Wt2PJKfz9TZqj26P8DZxtCO5kmNmovXP67m71Dh31LEifZ231-OHUF7JgF6Uqc32a2QLaJCvt7ZD_9lssWZ7HKVGzeu2aYA4b_J7_y7fPIPe3R0l93pHUl-0HH-HrsB9X22O-yQqOd7_HTVWDXb47t8uMKonj9g3z9h-N2O-TDAa9Z8UnOapA0z4Id9ezf_NsEF6tfP6ITgXVs0d5yiVi74ByDcCWrafMMP-Am0zXTRsclDRy_RDA2nIsX5QzY6-nh6eBz1YxeiUmaixYgyh1SmDm1a6SR4DLGKKjfCG-OqJCkypytCCqtkKg1UeWU0gCg9RmrKOS3SR2yrntbwhHGjTFqAAePiAnc453PhUDgK5SQh5Q3Y_uLAbdljktNojAuLsQmxyAYWWWKRDSwasFfLHZcdHsc_1r4nHi7XEZJ2eDBtzm2vmFYLoVFgEwdIItKaKxrAkiQpZB5MhSS-WEiARc2jdIqrYXo9s0IQ1pBOJa553EnE8lOUX461jgdMr8nKGi3rb-rJOKB7Z-QhGPP0fxD_jN2m46CauURts622uYbn6ES1xU64fNgJGvIbalAfbg
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Growth+Pattern+in+Chinese+Children+With+5%CE%B1-Reductase+Type+2+Deficiency%3A+A+Retrospective+Multicenter+Study&rft.jtitle=Frontiers+in+pharmacology&rft.au=Xiu+Zhao&rft.au=Xiu+Zhao&rft.au=Yanning+Song&rft.au=Shaoke+Chen&rft.date=2019-03-15&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=10&rft_id=info:doi/10.3389%2Ffphar.2019.00173&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_72270ff1ae0b4be8957467113e6fe8d4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon